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Introduction. Spontaneous nipple discharge is the third most common reason for presentation to a symptomatic breast clinic.
Benign and malignant causes of spontaneous nipple discharge continue to be diﬃcult to distinguish. We analyse our experience of
duct excisions for spontaneous nipple discharge to try to identify features that raise suspicion of breast cancer and to identify
features indicative of benign disease that would be suitable for nonoperative management. Methods. Details of one hundred
and ninety-four patients who underwent duct excision for spontaneous nipple discharge between 1995 and 2005 were analysed.
Results. Malignant disease was identiﬁed in 11 (5.7%) patients, 4 invasive and 7 insitu, which was 10.2% of those presenting
with bloodstained discharge. All patients with malignant disease had bloodstained discharge. Discharge due to malignant disease
was more likely to be bloodstained than that due to benign causes (Fisher’s exact test, 2-tailed P value = 0.00134). Conclusion.
Our ﬁndings do not support a policy of conservative management of spontaneous bloodstained nipple discharge. Cases of
demonstrablespontaneousbloodstainednippledischargeshouldundergoductexcisiontopreventmalignantlesionsbeingmissed.
1.Introduction
Nipple discharge is the third most common symptom pre-
senting to breast clinics, following lumps and pain [1],
accounting for 3 to 10% of referrals [2]. Nipple discharge
causes considerable anxiety, but it is a presenting symptom
in only 5 to 12% of cases of breast cancer [2]. Suspicious
discharge is described as being unilateral, single duct,
spontaneous, and persistent [3]. Discharge that is clear,
serous, sero-sanguinous, or bloodstained is more likely to be
due to breast cancer [4].
Approximately, 55% of patients presenting with nipple
discharge have an associated mass, 19% of which are
malignant [3]. These patients should be investigated by the
triple assessment. In some patients who do not have a pal-
pable breast lesion, mammography identiﬁes an abnormality
whichrequiresfurtherinvestigation.Theremainderwillhave
neither a palpable nor a radiological abnormality. Where the
natureofthedischargeissuspicious,ductexcisionisrequired
to exclude breast cancer.
Although not routine practice in the United Kingdom, a
number of techniques have been used to determine the cause
of nipple discharge, beyond the triple assessment. Nipple
discharge cytology has a low sensitivity for the detection of
breast cancer [4, 5] and is unlikely to alter the management
of patients with nipple discharge [4, 6]. Fluorescent insitu
hybridization analysis of the discharge has not yet entered
clinical practice however, a small pilot study has shown that
it has a 100% speciﬁcity in making a deﬁnitive diagnosis of
malignancy in patients with indeterminate cytologic results,
suggesting that it could be a good adjunct to cytology [7].
Ductography has a high-positive predictive factor in the
diagnosis of intraductal lesions, papilloma, and carcinoma;
however, it has a low sensitivity and is painful [8]. Breast
ductoscopy is an evolving technology, which is a promising
tool as it can allow identiﬁcation of the site of any lesion
in younger women, allowing excision of the benign lesions
while retaining the ability to lactate. However, further
studies are required to deﬁne its role more clearly, as there
are still limitations in clinical practice [8–15]. Magnetic2 International Journal of Breast Cancer
resonanceimaging(MRI)mayplayanadjunctiverole,aiding
in the diﬀerentiation of benign ductal abnormalities from
malignant ones but remains under investigation and is not
themethodofchoicepresentlyinevaluatingnippledischarge
in the UK [16–19].
Onlyductexcisionprovidesadeﬁnitivehistologicaldiag-
nosis and remains the gold standard. However, a signiﬁcant
number of patients with benign conditions undergo surgery,
which is a concern particularly in women of child bearing
age due to the implications associated with breastfeeding.
The aim of this study was to analyse our experience of
duct excision for nipple discharge, in an attempt to identify
features that raise the suspicion of breast cancer, and to
identify features indicative of benign disease where duct
excision can be avoided.
2. Methods
All patients who underwent microdochectomy or total duct
excision for spontaneous nipple discharge between 1995
and 2005 were analysed. Patients were managed by two
consultant breast surgeons, who performed or supervised all
surgical procedures. Data that was collected prospectively on
the British Association of Surgical Oncology Database was
retrieved and analysed.
During this period, 1964 patients presented with sponta-
neous nipple discharge, either alone or in combination with
other symptoms. Triple assessment diagnosed breast cancer
in 62 patients and benign causes in 1708. In the absence of a
clinicalorradiologicalabnormalitytoallowadeﬁnitebenign
or malignant diagnosis, duct excision was performed if the
nature of the discharge caused concern.
One hundred and ninety-four patients, including 1 man,
underwent duct excision for spontaneous nipple discharge
alone, median age 51, range 17–88 years (Figure 1). Two
women had a previous history of breast carcinoma; both pre-
sented with discharge on the contralateral side to a previous
mastectomy. Fifty-eight patients had a past history of benign
breast disease.
3. Results
Onehundredandninety-fourductexcisionswereperformed
for spontaneous nipple discharge alone, 135 total duct exci-
sion,and59microdochectomies.Breastcancerwasidentiﬁed
in 11 (5.7%) patients: 4 invasive and 7 insitu (Table 1). Duct
ectasia and duct papilloma were the most common benign
diagnoses.
The median age of patients found to have bloodstained
discharge diagnosed to be breast cancer was 68 with a range
of 32–88. This was higher than that for patients who were
found to have benign disease, median age 50 with a range
17–84 years for patients with benign disease.
All patients diagnosed with breast cancer, following
ductexcision(Table 2),subsequentlyunderwentmastectomy
with either axillary sampling or clearance. One patient was
initially treated by central wide local excision, but disease-
free margins could not be obtained. All 4 cases of invasive
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Figure 1: Age distribution of patients undergoing surgery for
spontaneous isolated nipple discharge.
Table 1: Histology of duct excision specimens.
Histology Number % of total (195) Median age
(range)
Malignant 11 6% 68 (32–88)
IDC 4 2% 72 (68–74)
DCIS 7 4% 59 (32–88)
Benign 183 94% 50 (17–84)
Duct ectasia 76 39% 50 (22–84)
Papilloma 65 34% 56 (26–84)
Periductal mastitis 21 11% 39 (17–59)
Fibrocystic disease 12 6% 48 (35–65)
ADH 3 1% 61 (35–76)
Normal 6 3% 43 (24–67)
IDC: invasive ductal carcinoma.
DCIS: ductal carcinoma insitu.
ADH: atypical ductal hyperplasia.
carcinoma were grade 2 or 3 invasive ductal with associated
ductal carcinoma insitu. Two cases of DCIS were high grade,
4 intermediate grade, and 1 low grade. Nodal involvement
was not identiﬁed in any cases. There were no major dis-
crepancies between the histological diagnoses from the duct
excision and the subsequent therapeutic surgery, in 1 case,
the grade of DCIS was increased from low to intermediate.
None of these patients developed recurrent disease during
the 24–130 months followup.
Ten patients with breast cancer had unilateral single-
duct discharge, 1 had unilateral multiple duct discharge and
was found to have extensive intermediate grade DCIS. All
11 patients had some form of bloodstained discharge: 9
frankly bloodstained discharge, 1 altered blood, and 1 serous
discharge that was positive for blood on dipstick testing.
Discharge due to malignant disease was signiﬁcantly more
likely to be bloodstained than that due to benign causes
(Fisher’s exact test, 2-tailed P value = 0.001).
One hundred and eight patients (56%) who underwent
duct excision had bloodstained discharge. The median age
of patients with bloodstained discharge was higher than
thosewithnonbloodstaineddischarge:55,range24–88years,
versus 47, range 17–74 years, but did not reach statistical
signiﬁcance (Mann-Whitney test, P = 0.295).International Journal of Breast Cancer 3
Table 2: Breast cancers identiﬁed following surgery for spontaneous isolated nipple discharge.
Age Discharge type Single duct? Initial surgery Initial histology Final histology Treatment
32 Fresh blood Yes Micro DCIS Intermediate grade DCIS Mx + ANS + recon
43 Fresh blood No TDE DCIS Extensive intermediate grade
DCIS M x+A N S+r e c o n
51 Fresh blood/serous Yes TDE DCIS High grade DCIS Mx + ANS
58 Fresh blood Yes TDE IDC 3mmgrade3IDC+extensive
DCIS Mx + ANC + recon
60 Fresh blood Yes Micro DCIS High grade DCIS Mx + ANS
68 Fresh blood Yes TDE IDC 3mm grade 2 IDC + DCIS Mx + ANC
69 Fresh blood Yes Micro DCIS Multifocal intermediate grade
DCIS Mx + ANS
72
History of fresh blood;
serous discharge
identiﬁed, dipstick +++
for blood
Yes TDE IDC 10mm grade 2 IDC + DCIS Mx+ ANC
74 Altered blood Yes TDE IDC 10mm grade 2 IDC +
widespread DCIS Mx and ANC
78 Fresh blood Yes TDE DCIS Multifocal intermediate grade
DCIS Simple Mx
88 Fresh blood Yes TDE DCIS Low grade DCIS Simple Mx
Initial operation: Micro: microdochectomy; TDE: total duct excision.
Histology: DCIS: ductal carcinoma insitu; IDC: invasive ductal carcinoma.
Treatment: Mx: mastectomy; ANS: axillary node sampling; ANC: axillary node clearance; Recon: reconstruction.
Eleven of the 108 (10.2%) patients who had some form
of bloodstained nipple discharge were found to have invasive
or insitu breast cancer following duct excision (Table 3). No
cases of coloured discharge were associated with cancer.
Three patients were found to have atypical duct hyper-
plasia (ADH), of which 2 had frank bloodstained discharge
and 1 serous discharge with blood on dipstick testing.
Eight women with benign pathology at duct excision
have subsequently developed invasive breast cancer, 4 in the
ipsilateral and 4 in the contralateral breast, including 2 of the
3withADH(Table 4).Basedonthenationalregistrationrate
for breast cancer, in the 50–54 age group, (the median age of
patients in this study), in 2001 (the midpoint of this study),
3.2 breast cancers would be expected to develop during the
median follow-up period of 6 years [20].
A further 24 women with benign pathology at duct
excision reattended the Breast Clinic. Eighteen had symp-
toms on the same side as the duct excision, 4 contralateral,
and 2 bilateral (1 multiple papillomatosis and 1 requesting
bilateral reduction mammoplasty). The symptoms and signs
at representation were similar to the original pathologies
in 13 (54.2%), which was most commonly sepsis, previous
surgery having demonstrated subclinical periductal mastitis.
4. Discussion
The management of patients with spontaneous bloodstained
nipple discharge in the absence of other detectable abnor-
malities remains controversial. Reports have not shown an
increased risk of breast cancer in patients with nipple dis-
charge, with no other abnormality on triple assessment [21].
Table 3: Histology compared to type of discharge.
Histology Number Number with frank bloodstained
discharge (% of diagnostic group)
All 194 108 (56%)
Malignant 11 11 (100%)
IDC 4 4
DCIS 7 7
Benign 183 97 (53%)
Duct ectasia 76 43
Papilloma 65 36
Periductal mastitis 21 8
Fibrocystic disease 12 5
ADH 3 2
Normal 6 4
Several policies have been proposed, including conservative
management [22], or surgery for patients with suspicious or
bothersome discharge [4, 21].
Our ﬁndings do not support a policy of conservative
management of spontaneous bloodstained nipple discharge,
as 10.2% of patients were diagnosed to have breast cancer
in the absence of other clinical or radiological abnormality.
The median age of patients with bloodstained discharge due
to breast cancer was higher than that of the patients with
benign disease (68 versus 55 years) but with a large overlap
of ages. It has been suggested that a conservative policy
could be adopted for women under the age of 40 years [2].
However,inourseriesthiswouldhaveledustomissingacase4 International Journal of Breast Cancer
Table 4: Patients with benign diagnoses at duct excision, who subsequently represented with breast cancer.
Age at original
presentation Initial presentation Initial diagnosis Time to re-
presentation Side Subsequent
presentation
Further
histology Treatment
63
Bloodstained
single-duct nipple
discharge
ADH 16 months Contralateral
Serous nipple
discharge dipstick
+++ for blood
2mmgrade2
node negative
IDC +DCIS +
duct papilloma
Mx + ANC
77
Bloodstained
single-duct nipple
discharge
ADH 48 months Ipsilateral
Asymmetric density
seen on screening
mammogram follow
up
16mm grade 2
node negative
IDC
Mx + ANC
49 Serous single-duct
nipple discharge
Duct papilloma,
duct ectasia and
ﬁbrocystic disease
84 months Contralateral Breast pain and
nodularity
23mm grade 2
node negative
IDC + DCIS
Mx + ANC +
reconstruction.
Recurrence in
reconstructio
15 months later
treated with
WLE + DXT
(15mm grade 3
IDC)
52
Bloodstained
single-duct nipple
discharge
Fibrocystic
disease 94 months Ipsilateral Lump in axilla
Metastatic
adenocarcinoma
from presumed
occult breast
primary
ANC
59
Bloodstained
single-duct nipple
discharge
Duct ectasia 54 months Ipsilateral Lump
22mm grade 2
node negative
IDC
WLE + ANC +
DXT
62 Brown single-duct
nipple discharge Duct papilloma 56 months Ipsilateral Bloodstained nipple
discharge
Two adjacent
<5mmgrade2
node negative
IDC
Mx + ANC
67 Serous single-duct
nipple discharge Duct papilloma 26 months Contralateral
Bloodstained nipple
discharge and
nodularity
13mm grade 2
node negative
IDC, DCIS +
multiple duct
papillomas
WLE + ANS +
DXT
76 Clear single-duct
nipple discharge
Duct papilloma +
duct ectasia 6 weeks Contralateral New lump
14mm grade 2
node negative
IDC
Mx + ANC
Histology: DCIS: ductal carcinoma in situ; IDC: Invasive ductal carcinoma.
Treatment: Mx: mastectomy; ANS: axillary node sampling; ANC: axillary node clearance; WLE: wide local excision; DXT: radiotherapy.
of widespread intermediate grade DCIS that necessitated
mastectomy. From our data it would appear appropriate to
advocateconservativemanagementforwomenunder30,but
this would only have avoided 9 of 194 operations.
Locker et al. [23] advocated conservative management
of patients with all types of nipple discharge, suggesting
reinvestigation 1 year after presentation. They claimed that
any breast cancer not identiﬁed at presentation would still
be at a very early stage when a clinical or radiological
abnormality became apparent, which would not adversely
aﬀecttheoutcome.Ifthishadbeenappliedtoourseries,four
women with grade 2 invasive breast carcinoma would have
had a delayed diagnosis. It is not possible to predict when
their cancers would have become clinically or radiologically
detectable or what eﬀect that this would have had on prog-
nosis, but a delay in diagnosing breast cancer of more than
three months is considered to have prognostic signiﬁcance
[24]. Reviews have reported that DCIS progresses to invasive
cancer in 14–53% of cases over a period of at least 10 years
[25], that DCIS presenting with nipple discharge tends to be
extensive and has a high rate of local recurrence if treated
with breast conservation [26], and that higher grades of
DCIS are more likely to recur and to progress to high-
grade invasive disease [27]. Only 1 patient had low-grade
DCIS which would not support a policy of conservative
management.
Atypical ductal hyperplasia is associated with a risk of
developing breast carcinoma of around 10% within 10 years
[2]. Two of the 3 women were found to have ADH following
duct excision developed breast cancer within 4 years, 1 in
the contralateral breast. This raises the question of whether
symptomatic ADH may impart a higher risk of developingInternational Journal of Breast Cancer 5
breast cancer than incidentally identiﬁed ADH. Little data is
available, but ADH associated with DCIS has been reported
to increase the risk of contralateral breast cancer above that
ofDCISalone,andclearsurgicalmargins atductexcisionfor
ADH did not aﬀect the risk of developing breast cancer [28].
A further 6 women, 4 of who had presented with spon-
taneous bloodstained or serous discharge diagnosed with
benign diagnoses following duct excision, have gone on to
develop breast cancer, 3 in the contralateral breast. This
would suggest that presenting with bloodstained or serous
discharge may also be a marker of an increased risk of sub-
sequently developing breast cancer.
Dipstick testing of nipple discharge, for occult blood, to
identify those who require duct excision has been described
[29,30].Dipsticksareverysensitive,butareoflowspeciﬁcity.
We only use them when a patient clearly gives a history
of bloodstained discharge that is not conﬁrmed on clinical
examination, and then only accept +++ reading as a positive
test. In our series, 1 woman with breast cancer did not have
frank bloodstained discharge on clinical examination. She
gave a clear history of previously having blood in the dis-
charge, and the serous discharge identiﬁed on examination
tested positive for blood on dipstick testing.
The management of spontaneous bloodstained nipple
discharge remains open to optimisation. We believe that all
cases of demonstratable spontaneous bloodstained discharge
inpatientsovertheageof30yearsshouldundergodiagnostic
duct excision. However, duct excision should be avoided in
theabsenceofbloodstaininginordertopreventunnecessary
surgery and possible complications, as no patients were
identiﬁed to have breast cancer.
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